Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
Science Translational Medicine|May 24, 2023
Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastomaThomas Look, Emanuele Puca, Marcel Bühler, et al.
BMJ Neurology Open|May 7, 2026
Associations of chrononutrition and sleep with fatigue in multiple sclerosis: an analysis of the Swiss Multiple Sclerosis RegistryNicholas E Phillips, Vladeta Ajdacic-Gross, Jessica Rebeaud, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trialEmilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
Neurology|February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphomaAgnieszka Korfel, Eckhard Thiel, Peter Martus, et al.
Communications Medicine|June 24, 2024
Natural language processing analysis of the theories of people with multiple sclerosis about causes of their diseaseChristina Haag, Nina Steinemann, Vladeta Ajdacic-Gross, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2025
Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the radiotherapy delineation benchmark case procedureJonas Willmann, Joost J C Verhoeff, Orit Kaidar-Person, et al.
Acta Neuropathologica|January 6, 2024
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytomaMichael Weller, Jörg Felsberg, Bettina Hentschel, et al.
BMJ Neurology Open|April 8, 2026
Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosisMina Stanikić, Nina Steinemann, Jesús López-Alcalde, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2018
Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary siteFabian Wolpert, Michael Weller, Anna Sophie Berghoff, et al.
JAMA Oncology|May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical TrialDavid A Reardon, Alba A Brandes, Antonio Omuro, et al.
Pageof 24